Spliceosome Mutations in Uveal Melanoma.
DNA repair
chromosomes
epigenetic
genetic
metastatic disease
mutational analysis
prognosis
therapy
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
15 Dec 2020
15 Dec 2020
Historique:
received:
30
10
2020
revised:
10
12
2020
accepted:
12
12
2020
entrez:
18
12
2020
pubmed:
19
12
2020
medline:
16
3
2021
Statut:
epublish
Résumé
Uveal melanoma (UM) is the most common primary intraocular malignancy of the eye. It has a high metastatic potential and mainly spreads to the liver. Genetics play a vital role in tumor classification and prognostication of UM metastatic disease. One of the driver genes mutated in metastasized UM is subunit 1 of splicing factor 3b (
Identifiants
pubmed: 33333932
pii: ijms21249546
doi: 10.3390/ijms21249546
pmc: PMC7765440
pii:
doi:
Substances chimiques
Phosphoproteins
0
RNA Splicing Factors
0
SF3B1 protein, human
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Stichting Combined Ophthalmic Research Rotterdam
ID : CORR 5.2.0
Organisme : Stichting Steunfonds Uitzicht
ID : UZ-2018-4
Références
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Oncogene. 1998 Mar 5;16(9):1097-112
pubmed: 9528852
Nat Commun. 2017 Jan 09;8:14060
pubmed: 28067246
Leukemia. 2014 Jan;28(1):108-17
pubmed: 24113472
Genes Chromosomes Cancer. 2001 Mar;30(3):267-73
pubmed: 11170284
Nature. 2017 May 11;545(7653):175-180
pubmed: 28467829
Elife. 2017 Feb 08;6:
pubmed: 28177281
Ophthalmology. 2007 Dec;114(12):2309-15
pubmed: 17498805
Ophthalmology. 2017 Apr;124(4):573-575
pubmed: 27916271
Ophthalmology. 2008 Oct;115(10):1778-85
pubmed: 18554722
N Engl J Med. 2010 Dec 2;363(23):2191-9
pubmed: 21083380
Nature. 2019 Oct;574(7778):432-436
pubmed: 31597964
Cancer Discov. 2013 Oct;3(10):1122-1129
pubmed: 23861464
Nat Commun. 2016 Feb 04;7:10615
pubmed: 26842708
Crit Rev Oncol Hematol. 2019 Jan;133:74-83
pubmed: 30661660
N Engl J Med. 2011 Dec 29;365(26):2497-506
pubmed: 22150006
Arch Ophthalmol. 2005 Dec;123(12):1639-43
pubmed: 16344433
Cancer Cell. 2018 Jan 8;33(1):151
pubmed: 29316429
Mod Pathol. 2014 Oct;27(10):1321-30
pubmed: 24633195
Cancers (Basel). 2019 Aug 17;11(8):
pubmed: 31426461
Arch Ophthalmol. 2009 Aug;127(8):989-98
pubmed: 19667335
Prog Retin Eye Res. 2018 Sep;66:187-199
pubmed: 29571968
J Biol Chem. 1997 Mar 21;272(12):7883-91
pubmed: 9065455
J Antibiot (Tokyo). 1996 Dec;49(12):1204-11
pubmed: 9031665
Genes Dev. 2016 Dec 15;30(24):2710-2723
pubmed: 28087715
Oncotarget. 2016 Jan 26;7(4):4624-31
pubmed: 26683228
Eur J Cancer. 1997 Apr;33(5):787-91
pubmed: 9282118
Nat Rev Genet. 2016 Jul;17(7):407-421
pubmed: 27240813
Wiley Interdiscip Rev RNA. 2013 Jan-Feb;4(1):49-60
pubmed: 23044818
Int J Mol Sci. 2019 Nov 14;20(22):
pubmed: 31739488
Nat Med. 2016 Sep 7;22(9):976-86
pubmed: 27603132
Nature. 2015 Jul 2;523(7558):96-100
pubmed: 25970242
Cell Rep. 2018 Apr 3;23(1):282-296.e4
pubmed: 29617667
Nature. 2009 Jan 29;457(7229):599-602
pubmed: 19078957
Ophthalmology. 2000 Aug;107(8):1443-9
pubmed: 10919885
Cell Rep. 2015 Nov 3;13(5):1033-45
pubmed: 26565915
Nat Med. 2016 Jun;22(6):672-8
pubmed: 27135740
Nat Genet. 2013 Feb;45(2):133-5
pubmed: 23313955
ACS Chem Biol. 2014 Mar 21;9(3):643-8
pubmed: 24377313
Invest Ophthalmol Vis Sci. 2014 Aug 26;55(9):6024-30
pubmed: 25159205
J Cell Biochem. 1987 Apr;33(4):257-66
pubmed: 3034933
Nat Med. 2018 May;24(4):497-504
pubmed: 29457796
Genome Med. 2015 Oct 22;7:107
pubmed: 26490253
Clin Cancer Res. 2013 Nov 15;19(22):6296-304
pubmed: 23983259
Invest New Drugs. 2014 Jun;32(3):436-44
pubmed: 24258465
Nature. 2011 Sep 11;478(7367):64-9
pubmed: 21909114
Nat Chem Biol. 2007 Sep;3(9):570-5
pubmed: 17643112
Acta Ophthalmol. 2018 Jun;96(4):331-347
pubmed: 29105334
Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3595-3605
pubmed: 31425584
Proc Natl Acad Sci U S A. 1982 Dec;79(24):7842-6
pubmed: 6961456
ACS Chem Biol. 2011 Jun 17;6(6):582-9
pubmed: 21344922
Nat Commun. 2019 Jan 11;10(1):137
pubmed: 30635584
Cold Spring Harb Perspect Biol. 2011 Jul 01;3(7):
pubmed: 21441581
Oncotarget. 2017 May 30;8(22):36331-36338
pubmed: 28422737
Nat Genet. 2017 Mar;49(3):349-357
pubmed: 28135248
Nat Genet. 2011 Dec 11;44(1):47-52
pubmed: 22158541
Br J Ophthalmol. 1978 Jun;62(6):420-5
pubmed: 352389
Blood. 2015 Jul 9;126(2):233-41
pubmed: 25957392
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4651-9
pubmed: 14578381
Cancer Cell. 2016 Nov 14;30(5):750-763
pubmed: 27818134
Oncotarget. 2017 Dec 5;8(70):115018-115027
pubmed: 29383138
J Antibiot (Tokyo). 2002 Oct;55(10):855-62
pubmed: 12523818
Cancers (Basel). 2019 Aug 30;11(9):
pubmed: 31480356
Nature. 2012 Nov 15;491(7424):399-405
pubmed: 23103869
Science. 1991 May 10;252(5007):802-8
pubmed: 1902986
Nature. 2012 Jun 10;486(7403):353-60
pubmed: 22722193
Ophthalmology. 2012 Aug;119(8):1582-9
pubmed: 22503229
Nat Med. 2020 May;26(5):732-740
pubmed: 32341578
Nat Rev Mol Cell Biol. 2017 Mar;18(3):175-186
pubmed: 28096526
Melanoma Res. 2017 Jun;27(3):189-199
pubmed: 28296713
Science. 2010 Dec 3;330(6009):1410-3
pubmed: 21051595
Br J Cancer. 2013 Jul 23;109(2):493-6
pubmed: 23778528
Ophthalmology. 2016 May;123(5):1118-28
pubmed: 26923342
FEBS J. 2011 Dec;278(24):4870-80
pubmed: 21981285
J Pathol. 2015 Mar;235(4):571-80
pubmed: 25424858
Nat Genet. 2016 Jun;48(6):675-80
pubmed: 27089179
Nat Genet. 2013 Aug;45(8):933-6
pubmed: 23793026
Br J Cancer. 2009 Sep 1;101(5):813-5
pubmed: 19654573
Cell. 2017 Jan 12;168(1-2):20-36
pubmed: 27866654